Outcomes following a comprehensive versus a selective approach for infants born at 22 weeks of gestation.


Journal

Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884

Informations de publication

Date de publication:
01 2019
Historique:
received: 20 06 2018
accepted: 28 09 2018
revised: 20 09 2018
pubmed: 26 10 2018
medline: 21 3 2020
entrez: 25 10 2018
Statut: ppublish

Résumé

To examine outcomes at two institutions with different approaches to care among infants born at 22 weeks of gestation. Retrospective, cohort study (2006-2015). Enrollment was limited to mother-infant dyads at 22 weeks of gestation. Proactive care was defined as provision of antenatal corticosteroids and neonatal resuscitation and intensive care. One center (Uppsala, Sweden; UUCH) provided proactive care to all mother-infant dyads (comprehensive center); the other center (Nationwide Children's Hospital, USA; NCH) initiated or withheld treatment based on physician and family preferences (selective center). Differences in outcomes between the two centers were evaluated. Among 112 live-born infants at 22 weeks of gestation, those treated at UUCH had in-hospital survival rates higher than those at NCH (21/40, 53% vs. 6/72, 8%; P < 0.01). Among the subgroup of infants receiving proactive care (UUCH: 40/40, 100%; NCH: 16/72, 22%) survival was higher at UUCH than at NCH (21/40, 53% vs. 3/16, 19%; P < 0.05). Even when mother-infant dyads were provided proactive care at NCH (selective center), survival was lower than infants provided proactive care at UUCH (comprehensive center). Differences between the approaches to care at the two centers at 22 weeks of gestation merits further investigation.

Identifiants

pubmed: 30353079
doi: 10.1038/s41372-018-0248-y
pii: 10.1038/s41372-018-0248-y
doi:

Substances chimiques

Glucocorticoids 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-47

Commentaires et corrections

Type : CommentIn

Auteurs

Carl H Backes (CH)

Departments of Pediatrics and Obstetrics & Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH, USA. carl.backes@nationwidechildrens.org.
The Heart Center at Nationwide Children's Hospital, Columbus, OH, USA. carl.backes@nationwidechildrens.org.
The Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. carl.backes@nationwidechildrens.org.

Fanny Söderström (F)

Department of Women's and Children's Health, University Children's Hospital, Uppsala, Sweden.

Johan Ågren (J)

Department of Women's and Children's Health, University Children's Hospital, Uppsala, Sweden.

Richard Sindelar (R)

Department of Women's and Children's Health, University Children's Hospital, Uppsala, Sweden.

Christopher W Bartlett (CW)

Battelle Center for Mathematical Medicine, Nationwide Children's Hospital, Columbus, OH, USA.

Brian K Rivera (BK)

The Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.

Courtney C Mitchell (CC)

The Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.

Heather A Frey (HA)

Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Edward G Shepherd (EG)

The Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Department of Pediatrics, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Leif D Nelin (LD)

The Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Department of Pediatrics, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Erik Normann (E)

Department of Women's and Children's Health, University Children's Hospital, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH